Suchergebnisse - "ERACE-PA Global Study Group"

PubPharm (7)

1

In vitro activity of cefiderocol against a global collection of carbapenem-resistant Pseudomonas aeruginosa with a high level of carbapenemase diversity

enthalten in: The Journal of antimicrobial chemotherapy | 2024

von Gill, C. | Santini, D. | Nicolau, D. | +46

2

Activity of novel β-lactam/β-lactamase inhibitor combinations against serine carbapenemase-producing carbapenem-resistant Pseudomonas aeruginosa

enthalten in: The Journal of antimicrobial chemotherapy | 2023

von Lee, S. | Gill, C. | Nicolau, D. | +46

3

Piperacillin/Tazobactam Dose Optimization in the Setting of Piperacillin/Tazobactam-susceptible, Carbapenem-resistant Pseudomonas aeruginosa : Time to Reconsider Susceptible Dose Dependent

enthalten in: Clinical therapeutics | 2023

von Gill, C. | Nicolau, D. | ERACE-PA Global Study Group

4

Phenotypic and genotypic profile of ceftolozane/tazobactam-non-susceptible, carbapenem-resistant Pseudomonas aeruginosa

enthalten in: The Journal of antimicrobial chemotherapy | 2022

von Gill, C. | Nicolau, D. | ERACE-PA Global Study Group | +45

5

Carbapenem-resistant Pseudomonas aeruginosa : an assessment of frequency of isolation from ICU versus non-ICU, phenotypic and genotypic profiles in a multinational population of hospitalized patients

enthalten in: Antimicrobial resistance and infection control | 2022

von Gill, C. | Nicolau, D. | ERACE-PA Global Study Group

6

The ERACE-PA Global Surveillance Program : Ceftolozane/tazobactam and Ceftazidime/avibactam in vitro Activity against a Global Collection of Carbapenem-resistant Pseudomonas aeruginosa

enthalten in: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology | 2021

von Gill, C. | Aktaþ, E. | Alfouzan, W. | +17

7

Elevated MICs of Susceptible Antipseudomonal Cephalosporins in Non-Carbapenemase-Producing, Carbapenem-Resistant Pseudomonas aeruginosa : Implications for Dose Optimization

enthalten in: Antimicrobial agents and chemotherapy | 2021

von Gill, C. | Aktaş, E. | Alfouzan, W. | +16

1
[1]